Annual Drug Patent Expirations for FYARRO
Fyarro is a drug marketed by Aadi and is included in one NDA. There are four patents protecting this drug.
This drug has one hundred and three patent family members in thirty countries.
The generic ingredient in FYARRO is sirolimus. Additional details are available on the sirolimus profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com